MorphoSys Enters Into Business Combination Agreement To Be Acquired By Novartis For €2.7 Billion Equity Value; €68/Share In cash
https://www.eqs-news.com/company/morphosys-ag/news/5b719341-ea7c-11e8-902f-2c44fd856d8cMorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value Tafasitamab sold